SANA

SANA

Sana Biotechnology Inc

Rev โ€”top 1%5Y
Hold

Sana Biotechnology develops engineered cell therapies to treat diseases like type 1 diabetes and B cell malignancies. Its pipeline includes therapeutic candidates in various clinical stages and collaborates with institutions for advanced treatments.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$183today

Score Overview

1 Year
Scoreโ€”
Net Growth13.25%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth38.46%
Net Trend80%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth38.46%
Net Trend80%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency

See the full market ranking โ†’

Sana Biotechnology Inc fundamental performance

Across Sana Biotechnology Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 344M to -$ 244M. Revenue increased in 0% of the years measured; net income in 80%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 3.77โ€”
1 Year2025-08-12
$ 3.1121.22%
5 Years2021-08-12
$ 20.60-81.70%
All Time2021-02-04
$ 35.10-89.26%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 211M$ 160M
2025$ 0.00-$ 244M$ 138M
2024$ 0.00-$ 266M$ 152M
2023$ 0.00-$ 283M$ 205M
2022$ 0.00-$ 266M$ 423M
IPO2021$ 0.00-$ 344M$ 550M

Explore beyond SANA

You're looking at Sana Biotechnology Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies